サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
表紙：爪真菌症の世界市場規模調査＆予測、タイプ別（遠位爪甲下爪真菌症、表在性白色爪真菌症、近位爪甲下爪真菌症、その他タイプ）、治療法別（経口、局所、その他）、地域分析、2022-2029年
市場調査レポート
商品コード
1251571

爪真菌症の世界市場規模調査＆予測、タイプ別（遠位爪甲下爪真菌症、表在性白色爪真菌症、近位爪甲下爪真菌症、その他タイプ）、治療法別（経口、局所、その他）、地域分析、2022-2029年

Global Onychomycosis Market Size study & Forecast, by Type (Distal Subungual Onychomycosis, White Superficial Onychomycosis, Proximal Subungual Onychomycosis, Other Types) by Treatment (Oral, Topical, Others) and Regional Analysis, 2022-2029
出版日: | 発行: Bizwit Research & Consulting LLP | ページ情報: 英文 | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。

価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=157.14円
爪真菌症の世界市場規模調査＆予測、タイプ別（遠位爪甲下爪真菌症、表在性白色爪真菌症、近位爪甲下爪真菌症、その他タイプ）、治療法別（経口、局所、その他）、地域分析、2022-2029年
出版日: 2023年03月20日
発行: Bizwit Research & Consulting LLP
ページ情報: 英文
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

世界の爪真菌症市場は、2021年に約33億米ドルと評価され、予測期間2022-2029年には4.56%以上の健全な成長率で成長すると予測されています。

爪真菌症は爪の真菌感染症です。皮膚糸状菌や非皮膚糸状菌のカビが原因となることがあります。症状は、爪とその周囲の皮膚の物理的な変化で始まります。爪と組織は頻繁に白または黄色に変わり、爪は厚くなり、もろくなり、割れやすくなるかもしれません。このような状態の身体的な問題は、管理されなければ、顕著に悪化し、疼痛や炎症を引き起こすかもしれません。爪真菌症感染症の高い有病率、新薬の研究開発への投資の増加、高齢化人口の増加、慢性疾患の発生率の上昇、抗真菌薬の入手のしやすさなどが、市場の成長を促す要因となっています。

米国国立医学図書館によると、全世界で爪真菌症の感染者は10％存在するとされています。主な感染菌はTrichophyton rubrumと推定されます。その他、非皮膚菌のカビや皮膚糸状菌が爪真菌症の感染原因となっています。T. rubrum菌は感染症の98%で発見されました。さらに、製薬業界の研究開発費は、2019年に830億米ドルに達しました。2010年から2019年の間に、食品医薬品局（FDA）は平均で38の新薬を承認しており、これは、それ以前の10年間の年平均と比較して60％多いです。爪真菌症感染の増加、研究開発投資と新薬開発の増加が、市場拡大を促進する主な要因です。その他、高齢化社会の進展、慢性疾患の増加、抗真菌薬の入手のしやすさなども、市場拡大を後押しする重要な要素となっています。さらに、爪真菌症の治療に関する意識の高まりや糖尿病人口の増加が、予測期間中に大きな市場機会を生み出す要因となっています。しかし、爪真菌症の感染に対する認知度の低さが、2022-2029年の予測期間を通じて市場の成長を阻害しています。

爪真菌症の世界市場調査において考慮された主要地域は、アジア太平洋地域、北米、欧州、中南米、世界のその他の地域です。北米は、爪真菌症感染症の有病率の上昇、ヘルスケア支出の増加、爪真菌症治療薬に対する認知度の向上、研究開発における政府の取り組みの増加などにより、収益面で市場を独占しています。アジア太平洋は、爪真菌症の発生率の高さ、老人人口の増加、都市化の進展、主要企業の研究開発投資への注力などの要因から、予測期間中に最も高いCAGRで成長すると予想されます。

目次

第1章 エグゼクティブサマリー

  • マーケットスナップショット
  • 世界・セグメント別市場推定・予測、2019年～2029年
    • 爪真菌症市場、地域別、2019-2029年
    • 爪真菌症市場、タイプ別、2019-2029年
    • 爪真菌症市場、治療法別、2019-2029年
  • 主な動向
  • 調査手法
  • 調査の前提条件

第2章 爪真菌症の世界市場の定義とスコープ

  • 調査目的
  • 市場の定義と範囲
    • 調査対象範囲
    • 産業の進化
  • 本調査の対象となった年
  • 通貨換算レート

第3章 爪真菌症の世界市場力学

  • 爪真菌症市場のインパクト分析（2019-2029年）
    • 市場促進要因
      • 爪真菌症感染症の高い普及率
      • 新薬の研究開発への投資の増加
    • 市場の課題
      • 爪真菌症の感染に対する認識不足
    • マーケットオポチュニティ
      • 爪真菌症の治療に対する意識の高まり
      • 増加する糖尿病患者数

第4章 爪真菌症の世界市場産業分析

  • ポーターの5フォースモデル
    • 供給企業の交渉力
    • 買い手の交渉力
    • 新規参入業者の脅威
    • 代替品の脅威
    • 競争企業間の敵対関係
  • ポーターの5フォースモデルへの未来的アプローチ（2019-2029年）
  • PEST分析
    • 政治的
    • 経済的
    • ソーシャル
    • テクニカル
  • 投資採用モデル
  • アナリストの提言と結論
  • 最高の投資機会
  • 主要成功戦略

第5章 リスクアセスメントCOVID-19の衝撃

  • COVID-19が業界に与える全体的な影響についての評価
  • COVID-19以前とCOVID-19以後の市場シナリオ

第6章 爪真菌症の世界市場：タイプ別

  • マーケットスナップショット
  • 爪真菌症の世界市場：タイプ別、パフォーマンス別- ポテンシャル分析
  • 爪真菌症の世界市場タイプ別推定・予測2019-2029
  • 爪真菌症市場、サブセグメント分析
    • 遠位爪甲下爪真菌症
    • 表在性白色爪真菌症
    • 近位爪甲下爪真菌症
    • その他のタイプ

第7章 爪真菌症の世界市場、治療法別

  • マーケットスナップショット
  • 爪真菌症の世界市場：治療法別、パフォーマンス別- ポテンシャル分析
  • 爪真菌症の世界市場治療別推定・予測2019-2029
  • 爪真菌症市場、サブセグメント分析
    • 経口
    • 局所
    • その他

第8章 爪真菌症の世界市場：地域別分析

  • 爪真菌症市場、地域別市場スナップショット
  • 北米
    • 米国
      • タイプ別の推定・予測、2019年～2029年
      • 治療別の推定・予測、2019年～2029年
    • カナダ
  • 欧州爪真菌症市場スナップショット
    • 英国
    • ドイツ
    • フランス
    • スペイン
    • イタリア
    • その他欧州
  • アジア太平洋の爪真菌症市場スナップショット
    • 中国
    • インド
    • 日本
    • オーストラリア
    • 韓国
    • その他アジア太平洋地域
  • ラテンアメリカ爪真菌症市場スナップショット
    • ブラジル
    • メキシコ
  • 世界のその他の地域

第9章 競合情報

  • トップ市場戦略
  • 企業プロファイル
    • Bausch Health Companies Inc.
      • 主要な情報
      • 概要
      • 財務（データの入手が可能な場合のみ）
      • 製品概要
      • 最近の動向
    • Gsk Plc
    • Abbott
    • Pfizer Inc.
    • Bayer Ag
    • Teva Pharmaceutical Industries, Ltd.
    • Cipla Inc.
    • Novartis Ag
    • Sun Pharmaceutical Industries Ltd.
    • Merck & Co., Inc.

第10章 調査プロセス

  • 調査プロセス
    • データマイニング
    • 分析
    • 市場推定
    • バリデーション
    • 出版
  • 調査の特徴
  • 調査の前提条件
図表

LIST OF TABLES

  • TABLE 1. Global Onychomycosis Market, report scope
  • TABLE 2. Global Onychomycosis Market estimates & forecasts by Region 2019-2029 (USD Billion)
  • TABLE 3. Global Onychomycosis Market estimates & forecasts by Type 2019-2029 (USD Billion)
  • TABLE 4. Global Onychomycosis Market estimates & forecasts by Treatment 2019-2029 (USD Billion)
  • TABLE 5. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 6. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 7. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 8. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 9. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 10. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 11. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 12. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 13. Global Onychomycosis Market by segment, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 14. Global Onychomycosis Market by region, estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 15. U.S. Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 16. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 17. U.S. Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 18. Canada Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 19. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 20. Canada Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 21. UK Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 22. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 23. UK Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 24. Germany Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 25. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 26. Germany Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 27. France Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 28. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 29. France Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 30. Italy Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 31. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 32. Italy Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 33. Spain Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 34. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 35. Spain Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 36. RoE Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 37. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 38. RoE Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 39. China Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 40. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 41. China Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 42. India Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 43. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 44. India Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 45. Japan Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 46. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 47. Japan Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 48. South Korea Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 49. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 50. South Korea Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 51. Australia Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 52. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 53. Australia Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 54. RoAPAC Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 55. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 56. RoAPAC Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 57. Brazil Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 58. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 59. Brazil Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 60. Mexico Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 61. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 62. Mexico Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 63. RoLA Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 64. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 65. RoLA Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 66. Row Onychomycosis Market estimates & forecasts, 2019-2029 (USD Billion)
  • TABLE 67. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 68. Row Onychomycosis Market estimates & forecasts by segment 2019-2029 (USD Billion)
  • TABLE 69. List of secondary sources, used in the study of global Onychomycosis Market
  • TABLE 70. List of primary sources, used in the study of global Onychomycosis Market
  • TABLE 71. Years considered for the study
  • TABLE 72. Exchange rates considered

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

LIST OF FIGURES

List of figures

  • FIG 1. Global Onychomycosis Market, research methodology
  • FIG 2. Global Onychomycosis Market, Market estimation techniques
  • FIG 3. Global Market size estimates & forecast methods
  • FIG 4. Global Onychomycosis Market, key trends 2021
  • FIG 5. Global Onychomycosis Market, growth prospects 2022-2029
  • FIG 6. Global Onychomycosis Market, porters 5 force model
  • FIG 7. Global Onychomycosis Market, pest analysis
  • FIG 8. Global Onychomycosis Market, value chain analysis
  • FIG 9. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 10. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 11. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 12. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 13. Global Onychomycosis Market by segment, 2019 & 2029 (USD Billion)
  • FIG 14. Global Onychomycosis Market, regional snapshot 2019 & 2029
  • FIG 15. North America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 16. Europe Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 17. Asia pacific Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 18. Latin America Onychomycosis Market 2019 & 2029 (USD Billion)
  • FIG 19. Global Onychomycosis Market, company Market share analysis (2021)

List of tables and figures and dummy in nature, final lists may vary in the final deliverable

目次

Global Onychomycosis Market is valued at approximately USD 3.3 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 4.56% over the forecast period 2022-2029. Onychomycosis is a fungal infection of the nails, and can also be referred to as dermatophytic onychomycosis. This can be a cause of dermatophytes and nondermatophytic molds. The symptoms begin with physical alterations to the nail and surrounding skin. The nail and tissue frequently turn white or yellow, and the nails might thicken and become brittle, making them more likely to break. Physical problems in this condition might deteriorate noticeably and cause pain and inflammation if not managed. The high prevalence of Onychomycosis infections, increasing investments in the R&D of novel drugs, increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs are the factors driving the growth of the market.

According to the National Library of Medicine, there is 10% of the Onychomycosis infected population across the globe. Trichophyton rubrum was estimated to be the main infecting organism. Nondermatophyte mould and dermatophytes are the other causes of Onychomycosis infections. T. rubrum organisms were found in 98% of the infections. Additionally, The R&D expenditure in the pharmaceutical industry amounted to 83 billion dollars in 2019. Between 2010 and 2019, the Food and Drug Administration (FDA) approved 38 new medications on average, which is 60% more than it did on an annual average over the preceding ten years. Increasing Onychomycosis infections and increasing R&D investments and development of new drugs are the major factors driving the market growth. Other important components driving market increase are the increasing ageing population, rising incidence of chronic diseases, and easy accessibility of antifungal drugs. Furthermore, rising awareness about the treatment of Onychomycosis and the growing Diabetic Population are the factors creating major market opportunities in the forecast period. However, the lack of awareness of onychomycosis infections stifles market growth throughout the forecast period of 2022-2029.

The key regions considered for the Global Onychomycosis Market study includes Asia Pacific, North America, Europe, Latin America, and Rest of the World. North America dominated the market in terms of revenue, owing to the rising prevalence of Onychomycosis infections, increasing healthcare expenditures, increase in the awareness of Onychomycosis drugs, and increasing government initiatives in R&D. Asia Pacific is expected to grow with the highest CAGR during the forecast period, owing to factors such as high incidence of Onychomycosis infections, a growing geriatric population, increasing urbanization and focus of key players on investing in R&D.

Major market players included in this report are:

  • Bausch Health Companies Inc.
  • Gsk Plc
  • Abbott
  • Pfizer Inc.
  • Bayer Ag
  • Teva Pharmaceutical Industries, Ltd.
  • Cipla Inc.
  • Novartis Ag
  • Sun Pharmaceutical Industries Ltd.
  • Merck & Co., Inc.

Recent Developments in the Market:

  • In March 2021, The Tianjin Institute of Pharmaceutical Research and HUYABIO International joint venture, submitted a new drug application efinaconazole, as Jublia™ for the treatment of onychomycosis.
  • In July 2021, Kaken Pharmaceutical (KKPCF) and Almirall S.A., a global biopharmaceutical company specializing in skin health, announced that they have signed a license and distribution agreement under which Kaken Pharmaceutical gives Almirall the exclusive right to develop and market the topical formulation of efinaconazole in Europe.

Global Onychomycosis Market Report Scope:

  • Historical Data 2019-2020-2021
  • Base Year for Estimation 2021
  • Forecast period 2022-2029
  • Report Coverage Revenue forecast, Company Ranking, Competitive Landscape, Growth factors, and Trends
  • Segments Covered Type, Treatment, Region
  • Regional Scope North America; Europe; Asia Pacific; Latin America; Rest of the World
  • Customization Scope Free report customization (equivalent up to 8 analyst's working hours) with purchase. Addition or alteration to country, regional & segment scope*

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within countries involved in the study.

The report also caters detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, it also incorporates potential opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:

By Type:

  • Distal Subungual Onychomycosis
  • White Superficial Onychomycosis
  • Proximal Subungual Onychomycosis
  • Other Types

By Treatment:

  • Oral
  • Topical
  • Others

By Region:

  • North America
  • U.S.
  • Canada
  • Europe
  • UK
  • Germany
  • France
  • Spain
  • Italy
  • ROE
  • Asia Pacific
  • China
  • India
  • Japan
  • Australia
  • South Korea
  • RoAPAC
  • Latin America
  • Brazil
  • Mexico
  • Rest of the World

Table of Contents

Chapter 1. Executive Summary

  • 1.1. Market Snapshot
  • 1.2. Global & Segmental Market Estimates & Forecasts, 2019-2029 (USD Billion)
    • 1.2.1. Onychomycosis Market, by Region, 2019-2029 (USD Billion)
    • 1.2.2. Onychomycosis Market, by Type, 2019-2029 (USD Billion)
    • 1.2.3. Onychomycosis Market, by Treatment, 2019-2029 (USD Billion)
  • 1.3. Key Trends
  • 1.4. Estimation Methodology
  • 1.5. Research Assumption

Chapter 2. Global Onychomycosis Market Definition and Scope

  • 2.1. Objective of the Study
  • 2.2. Market Definition & Scope
    • 2.2.1. Scope of the Study
    • 2.2.2. Industry Evolution
  • 2.3. Years Considered for the Study
  • 2.4. Currency Conversion Rates

Chapter 3. Global Onychomycosis Market Dynamics

  • 3.1. Onychomycosis Market Impact Analysis (2019-2029)
    • 3.1.1. Market Drivers
      • 3.1.1.1. High prevalence of Onychomycosis infections
      • 3.1.1.2. Increasing investments in the R&D of novel drugs
    • 3.1.2. Market Challenges
      • 3.1.2.1. Lack of awareness of onychomycosis infections
    • 3.1.3. Market Opportunities
      • 3.1.3.1. Rising awareness about the treatment of Onychomycosis
      • 3.1.3.2. Growing Diabetic Population

Chapter 4. Global Onychomycosis Market Industry Analysis

  • 4.1. Porter's 5 Force Model
    • 4.1.1. Bargaining Power of Suppliers
    • 4.1.2. Bargaining Power of Buyers
    • 4.1.3. Threat of New Entrants
    • 4.1.4. Threat of Substitutes
    • 4.1.5. Competitive Rivalry
  • 4.2. Futuristic Approach to Porter's 5 Force Model (2019-2029)
  • 4.3. PEST Analysis
    • 4.3.1. Political
    • 4.3.2. Economical
    • 4.3.3. Social
    • 4.3.4. Technological
  • 4.4. Investment Adoption Model
  • 4.5. Analyst Recommendation & Conclusion
  • 4.6. Top investment opportunity
  • 4.7. Top winning strategies

Chapter 5. Risk Assessment: COVID-19 Impact

  • 5.1. Assessment of the overall impact of COVID-19 on the industry
  • 5.2. Pre COVID-19 and post COVID-19 Market scenario

Chapter 6. Global Onychomycosis Market, by Type

  • 6.1. Market Snapshot
  • 6.2. Global Onychomycosis Market by Type, Performance - Potential Analysis
  • 6.3. Global Onychomycosis Market Estimates & Forecasts by Type 2019-2029 (USD Billion)
  • 6.4. Onychomycosis Market, Sub Segment Analysis
    • 6.4.1. Distal Subungual Onychomycosis
    • 6.4.2. White Superficial Onychomycosis
    • 6.4.3. Proximal Subungual Onychomycosis
    • 6.4.4. Other Types

Chapter 7. Global Onychomycosis Market, by Treatment

  • 7.1. Market Snapshot
  • 7.2. Global Onychomycosis Market by Treatment, Performance - Potential Analysis
  • 7.3. Global Onychomycosis Market Estimates & Forecasts by Treatment 2019-2029 (USD Billion)
  • 7.4. Onychomycosis Market, Sub Segment Analysis
    • 7.4.1. Oral
    • 7.4.2. Topical
    • 7.4.3. Others

Chapter 8. Global Onychomycosis Market, Regional Analysis

  • 8.1. Onychomycosis Market, Regional Market Snapshot
  • 8.2. North America Onychomycosis Market
    • 8.2.1. U.S. Onychomycosis Market
      • 8.2.1.1. Type breakdown estimates & forecasts, 2019-2029
      • 8.2.1.2. Treatment breakdown estimates & forecasts, 2019-2029
    • 8.2.2. Canada Onychomycosis Market
  • 8.3. Europe Onychomycosis Market Snapshot
    • 8.3.1. U.K. Onychomycosis Market
    • 8.3.2. Germany Onychomycosis Market
    • 8.3.3. France Onychomycosis Market
    • 8.3.4. Spain Onychomycosis Market
    • 8.3.5. Italy Onychomycosis Market
    • 8.3.6. Rest of Europe Onychomycosis Market
  • 8.4. Asia-Pacific Onychomycosis Market Snapshot
    • 8.4.1. China Onychomycosis Market
    • 8.4.2. India Onychomycosis Market
    • 8.4.3. Japan Onychomycosis Market
    • 8.4.4. Australia Onychomycosis Market
    • 8.4.5. South Korea Onychomycosis Market
    • 8.4.6. Rest of Asia Pacific Onychomycosis Market
  • 8.5. Latin America Onychomycosis Market Snapshot
    • 8.5.1. Brazil Onychomycosis Market
    • 8.5.2. Mexico Onychomycosis Market
  • 8.6. Rest of The World Onychomycosis Market

Chapter 9. Competitive Intelligence

  • 9.1. Top Market Strategies
  • 9.2. Company Profiles
    • 9.2.1. Bausch Health Companies Inc.
      • 9.2.1.1. Key Information
      • 9.2.1.2. Overview
      • 9.2.1.3. Financial (Subject to Data Availability)
      • 9.2.1.4. Product Summary
      • 9.2.1.5. Recent Developments
    • 9.2.2. Gsk Plc
    • 9.2.3. Abbott
    • 9.2.4. Pfizer Inc.
    • 9.2.5. Bayer Ag
    • 9.2.6. Teva Pharmaceutical Industries, Ltd.
    • 9.2.7. Cipla Inc.
    • 9.2.8. Novartis Ag
    • 9.2.9. Sun Pharmaceutical Industries Ltd.
    • 9.2.10. Merck & Co., Inc.

Chapter 10. Research Process

  • 10.1. Research Process
    • 10.1.1. Data Mining
    • 10.1.2. Analysis
    • 10.1.3. Market Estimation
    • 10.1.4. Validation
    • 10.1.5. Publishing
  • 10.2. Research Attributes
  • 10.3. Research Assumption